Five-year follow-up of "total therapy" of childhood lymphocytic leukemia.
D000284:Administration, Oral; D000963:Antimetabolites / Q000008:administration & dosage; D002490:Central Nervous System / Q000528:radiation effects; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D007278:Injections, Spinal; D007945:Leukemia, Lymphoid / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011830:Radiation Effects; D012737:Sex Factors; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D000963:Antimetabolites; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate